MCID: SML034
MIFTS: 36

Small Cell Neuroendocrine Carcinoma

Categories: Cancer diseases, Respiratory diseases, Neuronal diseases

Aliases & Classifications for Small Cell Neuroendocrine Carcinoma

MalaCards integrated aliases for Small Cell Neuroendocrine Carcinoma:

Name: Small Cell Neuroendocrine Carcinoma 12 14
Carcinoma, Small Cell 69

Classifications:



External Ids:

Disease Ontology 12 DOID:0050875

Summaries for Small Cell Neuroendocrine Carcinoma

MalaCards based summary : Small Cell Neuroendocrine Carcinoma, also known as carcinoma, small cell, is related to adenocarcinoma in situ and lung cancer. An important gene associated with Small Cell Neuroendocrine Carcinoma is SYP (Synaptophysin), and among its related pathways/superpathways are Pathways in cancer and Oncogene Induced Senescence. The drugs Cisplatin and Carboplatin have been mentioned in the context of this disorder. Affiliated tissues include lung, cervix and prostate.

Related Diseases for Small Cell Neuroendocrine Carcinoma

Diseases in the Large Cell Neuroendocrine Carcinoma family:

Small Cell Neuroendocrine Carcinoma

Diseases related to Small Cell Neuroendocrine Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 313)
id Related Disease Score Top Affiliating Genes
1 adenocarcinoma in situ 29.9 CDKN2A TP53
2 lung cancer 26.8 CDKN2A CHGA ENO2 KIT NCAM1 SYP
3 urinary bladder small cell neuroendocrine carcinoma 12.2
4 small cell cancer of the lung, somatic 11.1
5 malignant ovarian mixed epithelial neoplasm 10.7 CHGA SYP
6 spinal cord ependymoma 10.7 CHGA SYP
7 signet ring cell intrahepatic cholangiocarcinoma 10.7 CHGA SYP
8 esophagus adenocarcinoma 10.7 CHGA SYP
9 basophilic carcinoma 10.7 CHGA SYP
10 neurogenic thoracic outlet syndrome 10.7 CHGA SYP
11 aicardi-goutieres syndrome 10.7 CHGA SYP
12 diffuse infiltrative lymphocytosis syndrome 10.7 CHGA SYP
13 reticular pattern testicular yolk sac tumor 10.7 CHGA SYP
14 2q31.1 microdeletion syndrome 10.7 ENO2 SYP
15 supratentorial primitive neuroectodermal tumor 10.7 CHGA ENO2
16 enteric pattern testicular yolk sac tumor 10.7 CHGA ENO2
17 gorlin bushkell jensen syndrome 10.7 CHGA ENO2
18 central nervous system hematologic cancer 10.7 CHGA SYP
19 rete ovarii cystadenofibroma 10.6 CHGA SYP
20 paranasal sinus cancer 10.6 ENO2 SYP
21 parietal lobe neoplasm 10.6 CHGA ENO2
22 situs inversus totalis with cystic dysplasia of kidneys and pancreas 10.6 ENO2 SYP
23 perianal skin paget's disease 10.6 CHGA SYP
24 fallopian tube adenomatoid tumor 10.6 CHGA ENO2
25 bronchus adenoma 10.6 ENO2 SYP
26 pemphigus foliaceus 10.6 ENO2 SYP
27 hepatorenal syndrome 10.6 CHGA SYP
28 tricuspid valve insufficiency 10.6 CHGA SYP
29 skin papilloma 10.6 ENO2 SYP
30 brain stem ependymoma 10.6 CHGA SYP
31 bladder benign neoplasm 10.6 CHGA ENO2
32 cauda equina intradural extramedullary astrocytoma 10.6 ENO2 SYP
33 thymus large cell carcinoma 10.6 ENO2 SYP
34 cauda equina neoplasm 10.6 ENO2 SYP
35 mature teratoma 10.6 ENO2 SYP
36 axonal neuropathy 10.6 ENO2 SYP
37 malignant granular cell myoblastoma 10.6 ENO2 SYP
38 behcet's syndrome arthropathy 10.6 ENO2 SYP
39 proliferative type fibrocystic change of breast 10.6 ENO2 SYP
40 bladder cancer, childhood 10.6 CHGA SYP
41 sensory organ benign neoplasm 10.6 ENO2 SYP
42 neuritis 10.6 NCAM1 SYP
43 diphtheria 10.6 CHGA ENO2
44 hypogonadotropic hypogonadism without anosmia, x-linked 10.6 NCAM1 SYP
45 spondyloepimetaphyseal dysplasia, isidor type 10.6 ENO2 SYP
46 classic variant of chromophobe renal cell carcinoma 10.6 CHGA SYP
47 alpha chain disease 10.6 ENO2 SYP
48 arteriosclerosis obliterans 10.6 ENO2 NCAM1
49 verruciform xanthoma of skin 10.6 ENO2 NCAM1
50 sm-ahnmd 10.6 NCAM1 SYP

Graphical network of the top 20 diseases related to Small Cell Neuroendocrine Carcinoma:



Diseases related to Small Cell Neuroendocrine Carcinoma

Symptoms & Phenotypes for Small Cell Neuroendocrine Carcinoma

Drugs & Therapeutics for Small Cell Neuroendocrine Carcinoma

Drugs for Small Cell Neuroendocrine Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 90)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cisplatin Approved Phase 3,Phase 2,Phase 1 15663-27-1 84093 441203 2767
2
Carboplatin Approved Phase 3,Phase 2 41575-94-4 10339178 498142 38904
3
Etoposide Approved Phase 3,Phase 2,Phase 1 33419-42-0 36462
4
Doxycycline Approved, Investigational, Vet_approved Phase 3 564-25-0 54671203
5 Povidone-iodine Approved Phase 3 25655-41-8
6
Tremelimumab Investigational Phase 3,Phase 2 745013-59-6
7 Antibodies Phase 3,Phase 2
8 Antibodies, Monoclonal Phase 3,Phase 2
9 Antineoplastic Agents, Phytogenic Phase 3,Phase 2,Phase 1
10 Immunoglobulins Phase 3,Phase 2
11 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1
12 Anti-Bacterial Agents Phase 3,Phase 2
13 Anti-Infective Agents Phase 3,Phase 1
14 Etoposide phosphate Phase 3,Phase 2,Phase 1
15 Antimalarials Phase 3
16 Antiparasitic Agents Phase 3
17 Antiprotozoal Agents Phase 3
18
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
19
Cyclophosphamide Approved, Investigational Phase 2 50-18-0, 6055-19-2 2907
20
Lenograstim Approved Phase 2 135968-09-1
21
Paclitaxel Approved, Vet_approved Phase 2,Phase 1 33069-62-4 36314
22
Topotecan Approved, Investigational Phase 2,Phase 1 119413-54-6, 123948-87-8 60700
23
Cetuximab Approved Phase 2,Phase 1 205923-56-4 56842117 2333
24
Xylometazoline Approved Phase 2 526-36-3 5709
25
Somatostatin Approved Phase 1, Phase 2 38916-34-6, 51110-01-1 53481605
26
Doxorubicin Approved, Investigational Phase 2 23214-92-8 31703
27
Fluorouracil Approved Phase 2 51-21-8 3385
28
Ifosfamide Approved Phase 2 3778-73-2 3690
29
Mechlorethamine Approved Phase 2 51-75-2 4033
30
Olaparib Approved Phase 2 763113-22-0 23725625
31
leucovorin Approved, Nutraceutical Phase 2 58-05-9 143 6006
32
Camptothecin Experimental Phase 2 7689-03-4
33
Veliparib Investigational Phase 2,Phase 1 912444-00-9 11960529
34
Docetaxel Approved May 1996, Investigational Phase 2 114977-28-5 148124 9877265
35
Doxil Approved June 1999 Phase 2 31703
36
Cediranib Investigational Phase 2 288383-20-0 9933475
37 topoisomerase I inhibitors Phase 2,Phase 1
38 Albumin-Bound Paclitaxel Phase 2,Phase 1
39 Alkylating Agents Phase 2
40 Antimitotic Agents Phase 2,Phase 1
41 Antirheumatic Agents Phase 2
42 Immunosuppressive Agents Phase 2,Phase 1
43 Adjuvants, Immunologic Phase 2
44 Poly(ADP-ribose) Polymerase Inhibitors Phase 2,Phase 1
45 Antibiotics, Antitubercular Phase 2
46 Antimetabolites Phase 2,Phase 1
47 Antimetabolites, Antineoplastic Phase 2,Phase 1
48 Protein Kinase Inhibitors Phase 2,Phase 1
49 Hormone Antagonists Phase 1, Phase 2
50 Hormones Phase 1, Phase 2

Interventional clinical trials:

(show all 50)

id Name Status NCT ID Phase Drugs
1 A Study to Compare the Efficacy and Safety of Intrapleural Doxycycline Versus Iodopovidone for Performing Pleurodesis in Malignant Pleural Effusion Recruiting NCT02583282 Phase 3
2 Durvalumab+/- Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (Caspian) Recruiting NCT03043872 Phase 3 Durvalumab;Tremelimumab;Carboplatin;Cisplatin;Etoposide
3 Radiation Therapy in Preventing Brain Metastases in Patients With Small Cell Lung Cancer Withdrawn NCT00006344 Phase 3
4 Study of Relationship Between UGT1A1 Gene Polymorphism and Toxicity and Efficacy of Irinotecan in Small Cell Lung Cancer Unknown status NCT01635400 Phase 2 Irinotecan
5 Panitumumab, Cisplatin, and Pelvic Radiation Therapy in Treating Patients With Stage IB, Stage II, or Stage III Cervical Cancer Unknown status NCT01158248 Phase 2 cisplatin
6 Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours Unknown status NCT00323076 Phase 1, Phase 2 18F-FAZA PET Imaging
7 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Cancer. Completed NCT00003943 Phase 2 carboplatin;cyclophosphamide;paclitaxel;topotecan hydrochloride
8 Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer Completed NCT00907569 Phase 2
9 ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer Completed NCT00309959 Phase 2 Paclitaxel Albumin-Stabilized Nanoparticle Formulation
10 Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer Completed NCT00217633 Phase 2
11 Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer Completed NCT01266447 Phase 2 Topotecan Hydrochloride;Veliparib
12 Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Completed NCT00101192 Phase 2 cisplatin
13 Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer Completed NCT00276796 Phase 2 cisplatin;paclitaxel;topotecan hydrochloride
14 Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer Completed NCT00003379 Phase 1, Phase 2 cisplatin;paclitaxel
15 Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer Completed NCT01173523 Phase 2 STA-9090
16 Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium Recruiting NCT00756639 Phase 2
17 Trial of Topotecan With VX-970, an ATR Kinase Inhibitor, in Small Cell Cancers Recruiting NCT02487095 Phase 1, Phase 2 Topotecan;VX-970
18 PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers Recruiting NCT02936323 Phase 1, Phase 2 PEN-221
19 Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC) Recruiting NCT02995187 Phase 2 Apatinib Mesylate tablet
20 A Phase II, Multicenter Study of the EZH2 Inhibitor Tazemetostat in Adult Subjects With INI1-Negative Tumors or Relapsed/Refractory Synovial Sarcoma Recruiting NCT02601950 Phase 2 Tazemetostat
21 Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients Recruiting NCT02099188 Phase 2 Cisplatin;Docetaxel;5-fluorouracil;Etoposide;Adriamycin;Ifosfamide;Leucovorin
22 Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients Recruiting NCT02099175 Phase 2 Cisplatin;Docetaxel;5-fluorouracil;Etoposide;Adriamycin;Ifosfamide;Leucovorin
23 A Phase II, Study to Determine the Preliminary Efficacy of Novel Combinations of Treatment in Patients With Platinum Refractory Extensive-Stage Small-Cell Lung Cancer Recruiting NCT02937818 Phase 2 Durvalumab and Tremelimumab;AZD1775 and carboplatin (CBPT)
24 Olaparib With or Without Cediranib in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Recruiting NCT02893917 Phase 2 Cediranib;Olaparib
25 RRx-001 in Small, Non-small Cell Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT) Recruiting NCT02489903 Phase 2 RRx-001;Cisplatin/carboplatin plus albumin (nab-paclitaxel or Abraxane);cisplatin/carboplatin plus etoposide;carboplatin/paclitaxel.
26 Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer or Metastatic Large Cell Neuroendocrine Non-small Cell Lung Cancer Active, not recruiting NCT01642251 Phase 1, Phase 2 Cisplatin;Etoposide;Veliparib
27 A Feasibility Study Of NAB-Paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas Active, not recruiting NCT02215447 Phase 2 NAB paclitaxel;Carboplatin
28 Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Active, not recruiting NCT00416455 Phase 1, Phase 2 ferumoxtran-10
29 ADXS11-001 High Dose HPV+ Cervical Cancer Active, not recruiting NCT02164461 Phase 1, Phase 2
30 Antineoplaston Therapy in Treating Patients With Recurrent or Extensive-Stage Small Cell Lung Cancer Terminated NCT00003496 Phase 2 Antineoplaston therapy (Atengenal + Astugenal)
31 Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas Withdrawn NCT02030184 Phase 1, Phase 2 Rhenium Re 188-P2045
32 Hypofractionated Radiotherapy for Small Cell Lung Cancer Completed NCT00469222 Phase 1
33 Phase I Study of Weekly Topotecan in Combination With Sorafenib in Treatment of Relapsed Small Cell Lung Cancer Completed NCT00466232 Phase 1 Topotecan;Sorafenib
34 Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma Completed NCT00580320 Phase 1 Dacarbazine and bortezomib
35 A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers Completed NCT00926640 Phase 1 Belinostat;Cisplatin;Etoposide
36 Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Completed NCT00104910 Phase 1 Cisplatin
37 Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer Completed NCT00068549 Phase 1 Gemcitabine Hydrochloride;Cisplatin
38 Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma Recruiting NCT02881125 Phase 1 Nortriptyline Hydrochloride;Paclitaxel
39 SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine Carcinoma Recruiting NCT02500914 Phase 1 SC-002
40 Cone Beam CT Scanning in Lung and Bladder Cancer. Completed NCT00469066
41 Concurrent Chemo-radiation Form NSCLC to a Individualized MLD Completed NCT00572325
42 Radiotherapy for NSCLC to a Individualized MLD Completed NCT00573040
43 Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes Completed NCT00460356
44 Collecting Tumor Samples From Patients With Gynecological Tumors Completed NCT00897442
45 Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors Recruiting NCT02146170
46 International Ovarian & Testicular Stromal Tumor Registry Recruiting NCT01970696
47 Excretion of Acetylamantadine (AA) by Lung Cancer Patients During a Chemotherapy Regimen Recruiting NCT02331290
48 Mass Spectral Fingerprinting in Lung Cancer Recruiting NCT02781857
49 Use of Social Networking to Survey Women With Small and Large Cell Carcinomas of the Cervix Recruiting NCT01606293
50 Circulating Tumor DNA in Patients at High Risk for Lung Cancer Terminated NCT02715102

Search NIH Clinical Center for Small Cell Neuroendocrine Carcinoma

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Genetic Tests for Small Cell Neuroendocrine Carcinoma

Anatomical Context for Small Cell Neuroendocrine Carcinoma

MalaCards organs/tissues related to Small Cell Neuroendocrine Carcinoma:

39
Lung, Cervix, Prostate, Brain, Lymph Node, Tongue, Thyroid

Publications for Small Cell Neuroendocrine Carcinoma

Articles related to Small Cell Neuroendocrine Carcinoma:

(show top 50) (show all 141)
id Title Authors Year
1
Cytological features of adenocarcinoma admixed with small cell neuroendocrine carcinoma of the uterine cervix. ( 28603541 )
2017
2
Case report: term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix. ( 28754175 )
2017
3
Postradiotherapy small cell neuroendocrine carcinoma of base of tongue: An unusual clinical and site presentation. ( 27853043 )
2017
4
Small cell neuroendocrine carcinoma of the paranasal sinus with intraoral involvement: Report of a rare case and review of the literature. ( 28932042 )
2017
5
Amrubicin monotherapy may be an effective second-line treatment for patients with large-cell neuroendocrine carcinoma or high-grade non-small-cell neuroendocrine carcinoma. ( 28529747 )
2017
6
Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix. ( 27823771 )
2017
7
Small cell neuroendocrine carcinoma of the nasopharynx: a rare case report. ( 28536685 )
2017
8
FOXA2 is a sensitive and specific marker for small cell neuroendocrine carcinoma of the prostate. ( 28621319 )
2017
9
Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: a case report. ( 28174665 )
2017
10
Positron emission tomography/computed tomography imaging of adrenocorticotropic hormone-producing small-cell neuroendocrine carcinoma of the cervix. ( 28106911 )
2017
11
Report: Small cell neuroendocrine carcinoma (SCNEC) of the tongue: A case report. ( 28671105 )
2017
12
Primary small cell neuroendocrine carcinoma of the breast - A case report and review of the literature. ( 28734185 )
2017
13
Syndrome of inappropriate antidiuretic hormone associated with rectal small cell neuroendocrine carcinoma: a case report. ( 28852457 )
2017
14
Colonic small cell neuroendocrine carcinoma in a patient with long-standing ulcerative colitis treated with azathioprine. ( 27103360 )
2016
15
An Extremely Rare Case of Advanced Metastatic Small Cell Neuroendocrine Carcinoma of Sinonasal Tract. ( 27529044 )
2016
16
(68)Ga-DOTANOC PET-CT in a rare case of metastatic small cell neuroendocrine carcinoma of paranasal sinus. ( 26656431 )
2016
17
Ampullary carcinosarcoma with osteosarcomatous, small cell neuroendocrine carcinoma and conventional adenocarcinoma components; First report. ( 27640104 )
2016
18
Early Detection of Bone Metastasis in Small Cell Neuroendocrine Carcinoma of the Cervix by 68Ga-DOTATATE PET/CT Imaging. ( 28005640 )
2016
19
Sinonasal small cell neuroendocrine carcinoma: a systematic review of 80 patients. ( 26880574 )
2016
20
A Case of Pancreatic Small Cell Neuroendocrine Carcinoma Associated With SIADH. ( 27077720 )
2016
21
Alternative Splicing Provides a Novel Molecular Mechanism for Prostatic Small-cell Neuroendocrine Carcinoma. ( 27481176 )
2016
22
Small cell neuroendocrine carcinoma of the endometrium with pulmonary metastasis: A clinicopathologic study of a case and a brief review of the literature. ( 26900464 )
2016
23
Small-cell Neuroendocrine Carcinoma Associated with Non Adenoma-like Raised Lesion in a Patient with Long-standing Ulcerative Colitis. ( 26912579 )
2016
24
Mediastinum primary small cell neuroendocrine carcinoma. ( 27095946 )
2016
25
Small cell neuroendocrine carcinoma of tracheostomy site in a patient with a history of juvenile laryngeal papillomatosis. ( 27507691 )
2016
26
Thymic Small Cell Neuroendocrine Carcinoma Displayed on 18F-FDG PET/CT Imaging. ( 26673232 )
2016
27
The Role of CD44 in Glucose Metabolism in Prostatic Small Cell Neuroendocrine Carcinoma. ( 26832214 )
2016
28
Primary Ureteral Thyroid Transcription Factor 1-Positive Small Cell Neuroendocrine Carcinoma: Case Report and Review of the Literature. ( 26162396 )
2015
29
Should patients with laryngeal small cell neuroendocrine carcinoma receive prophylactic cranial irradiation? ( 26530293 )
2015
30
A rare cause of constipation: obstructing small cell neuroendocrine carcinoma of the anal canal. ( 26198995 )
2015
31
p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma. ( 25512615 )
2015
32
Small cell neuroendocrine carcinoma of the posterior tongue. ( 26458628 )
2015
33
Clinical outcomes of small cell neuroendocrine carcinoma and adenocarcinoma of the gallbladder. ( 25574101 )
2015
34
A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix. ( 25500455 )
2015
35
The CT and MRI observations of small cell neuroendocrine carcinoma in paranasal sinuses. ( 25888820 )
2015
36
Metastatic Small-Cell Neuroendocrine Carcinoma Simulating Circumscribed Choroidal Hemangioma. ( 27171748 )
2015
37
PD-L1 expression in small cell neuroendocrine carcinomas. ( 25582496 )
2015
38
Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix. ( 26186071 )
2015
39
Small cell neuroendocrine carcinoma of larynx: case series and literature review. ( 26173932 )
2015
40
Small cell neuroendocrine carcinoma of the ethmoid sinus revealed by syndrome of inappropriate antidiuretic hormone secretion. ( 26048029 )
2015
41
Small cell neuroendocrine carcinoma of the esophagus. ( 25645990 )
2015
42
A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications. ( 26254373 )
2015
43
Primary small cell neuroendocrine carcinoma of the oral cavity: A case report and review of the literature. ( 26622589 )
2015
44
Pseudomesotheliomatous small cell neuroendocrine carcinoma of the lung with calretinin expression. ( 25040312 )
2014
45
Prognostic Factors for Small Cell Neuroendocrine Carcinoma of the Uterine Cervix: An Institutional Experience. ( 24401981 )
2014
46
Submucosal small-cell neuroendocrine carcinoma of the larynx detected using (18)F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report and review of the literature. ( 25120658 )
2014
47
Response to MEK inhibitor in small cell neuroendocrine carcinoma of the cervix with a KRAS mutation. ( 26075998 )
2014
48
Rare sinonasal small cell neuroendocrine carcinoma evaluated by F-18-FDG PET/MRI. ( 24510632 )
2014
49
Radiation-Associated Small Cell Neuroendocrine Carcinoma of the Thyroid: A Case Report with Molecular Analyses. ( 23844610 )
2014
50
Metastatic small cell neuroendocrine carcinoma of the pyriform sinus evaluated by (18)F-FDG PET/CT. ( 25018134 )
2014

Variations for Small Cell Neuroendocrine Carcinoma

Copy number variations for Small Cell Neuroendocrine Carcinoma from CNVD:

7
id CNVD ID Chromosom Start End Type Gene Symbol CNVD Disease
1 226170 7 55086725 55275030 Not increased EGFR Small cell neuroendocrine carcinoma

Expression for Small Cell Neuroendocrine Carcinoma

Search GEO for disease gene expression data for Small Cell Neuroendocrine Carcinoma.

Pathways for Small Cell Neuroendocrine Carcinoma

Pathways related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1 11.52 CDKN2A KIT KLK3 TP53
2 10.76 CDKN2A TP53
3 10.5 CDKN2A TP53
4
Show member pathways
10.3 CDKN2A TP53

GO Terms for Small Cell Neuroendocrine Carcinoma

Cellular components related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 mast cell granule GO:0042629 8.62 CHGA KIT

Biological processes related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 mast cell degranulation GO:0043303 9.32 CHGA KIT
2 replicative senescence GO:0090399 9.26 CDKN2A TP53
3 somatic stem cell division GO:0048103 9.16 CDKN2A KIT
4 mast cell chemotaxis GO:0002551 8.96 CHGA KIT
5 mast cell cytokine production GO:0032762 8.62 CHGA KIT

Molecular functions related to Small Cell Neuroendocrine Carcinoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 disordered domain specific binding GO:0097718 8.32 TP53

Sources for Small Cell Neuroendocrine Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....